An avalanche startsfrom one pebble.

An accelerator in Hong Kong, at the head of the densest biomedical corridor in Asia.

Start a conversation

01 / The record

Built at the centre of Asia's densest biomedical corridor.


28Companies backed
11GBA cities
100%Hospital coverage across GBA

02 / Portfolio

28

Companies backed, one at a time. Not a cohort, not a fund page: the substance of the firm, so it is set at the size of the claim.

CG OncologyTherapeuticsDevelops bladder-sparing immunotherapies for bladder cancer.
KA ImagingDiagnosticsDevelops X-ray imaging technology for medical, veterinary and non-destructive testing.
Thrive BiosciencePlatformAutomated imaging, analytics and documentation of live cells and tissues.
OpharmicTherapeuticsDevelops non-invasive ultrasound platforms for medical treatment.
Phase ScientificDiagnosticsProvides diagnostic tools and services for cancer and infectious diseases.
PhnyX LabPlatformAn AI technology company developing AI-powered products and services.
All twenty eight

No cohorts. Every company, one on one.

03 / Backers

Who stands behind the cheque.

04 / What we do

We write the cheque, then stay close for a year.


INVESTMENT + 12 MONTHS ALONGSIDE

Capital is the door. The year that follows is the work. We help structure HK government grants, open hospital and university access, run regulatory pathways, and warm the next round well before you raise it. Plugged into Tigermed's CRO ecosystem from day one.

CONSULTING

On retainer, we run market entry, HK grant applications, hospital access, and partner introductions, for companies we'd back if our mandate fit. Same operators, same network.

MONTH 01Plan set. Milestones agreed.
MID-YEARFirst scientific proof of concept or partnership live.
MONTH 12Next round warm, data in hand.
The full year

05 / Team

The people you'll work with.


Emmanuel HuiEmmanuel HuiCEO
Isaac LuiIsaac LuiAssociate
Kelly HsuKelly HsuAnalyst
Rachel DingRachel DingAnalyst
Edith ChanEdith ChanExecutive Assistant

Five day to day. Behind them a board, an investment committee and the institutions that back us.

All five

06 / Affiliated · Strategic partner

Saltagen Ventures.Our sister fund.

An early-stage firm backing science and technology startups, run by operators on both sides of the Pacific.


01

Founded October 2017.

02

Bioscience, biomedical, AI/ML, media, edtech.

03

Backs defensible, patentable technology.

04

A venture-scaling conduit into Asia.

05

A streamlined next step for Pebble graduates.

Saltagen.com

If you are building it, we should talk.

Contact

pebbleadmin@tigerjadecapital.com

For companies beyond our investment scope, the same door.

LinkedIn

How to write to us

Pebble Accelerator / Tiger Jade / Hong Kong